Non-Communicable Risk Factors Highlight Drugmaker Opportunities
The prevalence of chronic non-communicable diseases is rising globally due to poor lifestyle habits and ageing populations. These factors differ between regions, highlighting differing demand for specific medicines. A thorough knowledge of these regional variations will provide multinational pharmaceutical firms with the ability to optimise their strategy based on product demand. We note that industry-specific factors such as the regulatory environment are equally influential for new product launches.